Carcinosarcomas (Malignant Mixed Müllerian Tumor) which are biphasic tumors with a carcinoma and a sarcoma component, show frequent CDKN2A overexpression and TP53 mutations (>90%)(9). Here, CDKN2A is linked to carcinosarcoma.